Non-[18F]FDG PET-Radiopharmaceuticals in Oncology. [PDF]
Dimitrakopoulou-Strauss A +2 more
europepmc +1 more source
Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma. [PDF]
Kim D, Lee SH, Hwang HS, Kim SJ, Yun M.
europepmc +1 more source
Immobilization of CuO onto melamine functionalized magnetic nanocomposite: an efficient catalyst for the Preparation of benzimidazole compounds. [PDF]
Asdollahpour Z, Baharfar R, Asghari S.
europepmc +1 more source
[<sup>18</sup>F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response. [PDF]
McNeal KC +5 more
europepmc +1 more source
Use of Radiomics in Characterizing Tumor Hypoxia. [PDF]
Huang M, Law HKW, Tam SY.
europepmc +1 more source
Radiation Therapy Personalization in Cancer Treatment: Strategies and Perspectives. [PDF]
Calvaruso M +3 more
europepmc +1 more source
Importance and Involvement of Imidazole Structure in Current and Future Therapy. [PDF]
Burlacu AP +7 more
europepmc +1 more source
An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. [PDF]
Liu D +10 more
europepmc +1 more source
Related searches:
Misonidazole neuropathy A prospective study
Journal of Neuro-Oncology, 1988The frequency with which polyneuropathy developed was investigated in patients with cancer of the larynx and pharynx who participated in a double-blind trial of the radiosensitizing drug misonidazole. Fourteen of 36 patients receiving misonidazole (total dose of about 11 g/m2) developed neuropathy, while this occurred in only 2 of 34 patients in the ...
Olaf B Paulson +2 more
exaly +5 more sources

